María Laura Fox

3.2k total citations
45 papers, 375 citations indexed

About

María Laura Fox is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, María Laura Fox has authored 45 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 23 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in María Laura Fox's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (21 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Hematopoietic Stem Cell Transplantation (8 papers). María Laura Fox is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (21 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Hematopoietic Stem Cell Transplantation (8 papers). María Laura Fox collaborates with scholars based in Spain, United States and United Kingdom. María Laura Fox's co-authors include Pere Barba, David Valcárcel, Steven Schnittman, Francesc Bosch, Olga Salamero, Guillermo Ortí, Andrew C. Perkins, Juan Carlos Hernández‐Boluda, Jean‐Jacques Kiladjian and James McCall and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

María Laura Fox

41 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
María Laura Fox Spain 12 203 126 79 60 45 45 375
David Ergas Israel 10 126 0.6× 129 1.0× 32 0.4× 68 1.1× 26 0.6× 18 344
Maki Hagihara Japan 11 223 1.1× 121 1.0× 47 0.6× 35 0.6× 95 2.1× 64 415
Kanchana Chansung Thailand 13 339 1.7× 171 1.4× 38 0.5× 72 1.2× 99 2.2× 40 544
Shigeru Oguma Japan 11 156 0.8× 76 0.6× 100 1.3× 117 1.9× 47 1.0× 22 396
Şeniz Öngören Türkiye 10 163 0.8× 100 0.8× 22 0.3× 35 0.6× 74 1.6× 57 388
Yosef Manor Israel 12 84 0.4× 95 0.8× 66 0.8× 56 0.9× 76 1.7× 27 467
Fumihiko Monma Japan 13 317 1.6× 120 1.0× 112 1.4× 42 0.7× 89 2.0× 35 496
A. Sarrat France 7 183 0.9× 63 0.5× 34 0.4× 124 2.1× 67 1.5× 22 447
Andrea Kew Canada 10 169 0.8× 32 0.3× 92 1.2× 84 1.4× 50 1.1× 25 290
Gabriella Sole Italy 10 195 1.0× 116 0.9× 62 0.8× 25 0.4× 14 0.3× 18 536

Countries citing papers authored by María Laura Fox

Since Specialization
Citations

This map shows the geographic impact of María Laura Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by María Laura Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites María Laura Fox more than expected).

Fields of papers citing papers by María Laura Fox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by María Laura Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by María Laura Fox. The network helps show where María Laura Fox may publish in the future.

Co-authorship network of co-authors of María Laura Fox

This figure shows the co-authorship network connecting the top 25 collaborators of María Laura Fox. A scholar is included among the top collaborators of María Laura Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with María Laura Fox. María Laura Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vachhani, Pankit, Ruben A. Mesa, John Mascarenhas, et al.. (2025). JAK inhibitor selection in challenging scenarios of myelofibrosis: a review. Haematologica.
2.
Walston, Leroy J., et al.. (2025). Ecovoltaic solar energy development can promote grassland bird communities. Journal of Applied Ecology. 62(12). 3341–3354.
3.
Harrison, Claire, Ruben A. Mesa, Moshe Talpaz, et al.. (2024). Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor–Naive or –Experienced Myelofibrosis Treated With Momelotinib. Clinical Lymphoma Myeloma & Leukemia. 25(3). 199–211. 2 indexed citations
4.
Oh, Stephen T., Srđan Verstovšek, Vikas Gupta, et al.. (2024). Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis. SHILAP Revista de lepidopterología. 5(1). 105–116. 12 indexed citations
5.
DeFilipp, Zachariah, María Laura Fox, Tobias A.W. Holderried, et al.. (2024). Systematic Review and Meta-Analysis of Extracorporeal Photopheresis for the Treatment of Steroid-Refractory Chronic Graft-Versus-Host Disease. Transplantation and Cellular Therapy. 31(2). 76.e1–76.e13.
6.
Walston, Leroy J., Heidi M. Hartmann, María Laura Fox, et al.. (2023). If you build it, will they come? Insect community responses to habitat establishment at solar energy facilities in Minnesota, USA. Environmental Research Letters. 19(1). 14053–14053. 23 indexed citations
7.
Palomo, Laura, María Laura Fox, Pamela Acha, et al.. (2023). Clonal Hematopoiesis of Indeterminate Potential (CHIP) Related to the Etiology of Ischemic Stroke. Blood. 142(Supplement 1). 5601–5601. 1 indexed citations
8.
Mesa, Ruben A., Claire Harrison, Jeanne Palmer, et al.. (2022). The Impact of Momelotinib on Patient Reported Quality of Life for Symptomatic and Anemic Patients with Myelofibrosis: Results from the Phase 3 Momentum Study. Blood. 140(Supplement 1). 9677–9680.
9.
Gerds, Aaron T., Srđan Verstovšek, Alessandro M. Vannucchi, et al.. (2022). Thrombocytopenic myelofibrosis (MF) patients previously treated with a JAK inhibitor in a phase 3 randomized study of momelotinib (MMB) versus danazol (DAN) [MOMENTUM].. Journal of Clinical Oncology. 40(16_suppl). 7061–7061. 5 indexed citations
10.
Mallen, Evan, María Laura Fox, Elizabeth Gillespie, et al.. (2022). Extreme Heat Exposure: Access and Barriers to Cooling Centers — Maricopa and Yuma Counties, Arizona, 2010–2020. MMWR Morbidity and Mortality Weekly Report. 71(24). 781–785. 9 indexed citations
11.
Passamonti, Francesco, James M. Foran, Valerio De Stefano, et al.. (2022). The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification. Blood. 140(Supplement 1). 583–585. 10 indexed citations
12.
Passamonti, Francesco, James M. Foran, María Laura Fox, et al.. (2022). S197: NAVITOCLAX PLUS RUXOLITINIB IN JAK INHIBITOR-NAÏVE PATIENTS WITH MYELOFIBROSIS: PRELIMINARY SAFETY AND EFFICACY IN A MULTICENTER, OPEN-LABEL PHASE 2 STUDY. HemaSphere. 6. 98–99. 8 indexed citations
13.
Hernández‐Boluda, Juan Carlos, Alberto Álvarez‐Larrán, José María Raya, et al.. (2022). Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis. Cancers. 14(9). 2331–2331. 3 indexed citations
14.
Fox, María Laura, Irene García‐Cadenas, Ariadna Pérez, et al.. (2020). Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis. Leukemia & lymphoma. 61(8). 1823–1832. 2 indexed citations
15.
García‐Cadenas, Irene, Estela Giménez, Pere Barba, et al.. (2019). Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 25(5). 1022–1030. 6 indexed citations
16.
17.
Fàbrega, Anna, Belén Viñado, María Laura Fox, et al.. (2017). Effectiveness of a Double-Carbapenem Regimen in a KPC-Producing Klebsiella pneumoniae Infection in an Immunocompromised Patient. Microbial Drug Resistance. 24(2). 199–202. 15 indexed citations
18.
Ortí, Guillermo, Pere Barba, María Laura Fox, et al.. (2016). Donor lymphocyte infusions in AML and MDS: Enhancing the graft-versus-leukemia effect. Experimental Hematology. 48. 1–11. 49 indexed citations
19.
Fox, María Laura, et al.. (2016). Aquatic Nuisance Species in the Great Lakes and Mississippi River Basin—A Risk Assessment in Support of GLMRIS. Environmental Management. 59(1). 154–173. 7 indexed citations
20.
Fox, María Laura, Pere Barba, Inmaculada Heras, et al.. (2014). A registry-based study of non-Aspergillus mould infections in recipients of allogeneic haematopoietic cell transplantation. Clinical Microbiology and Infection. 21(1). e1–e3. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Ergas Breakdown of academic impact, for papers by Maki Hagihara Breakdown of academic impact, for papers by Kanchana Chansung Breakdown of academic impact, for papers by Shigeru Oguma Breakdown of academic impact, for papers by Şeniz Öngören Breakdown of academic impact, for papers by Yosef Manor Breakdown of academic impact, for papers by Fumihiko Monma Breakdown of academic impact, for papers by A. Sarrat Breakdown of academic impact, for papers by Andrea Kew Breakdown of academic impact, for papers by Gabriella Sole
Rankless by CCL
2026